Simponi Golimumab 50 mg and 100 mg

Simponi is a prescription drug used to treat ulcerative colitis, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. It is also used to reduce  the effects of a substance in the body that can cause inflammation.To buy Simponi or to know its price contact 3S Corporation.

Manufacturer : Janssen Pharmaceuticals, Inc

Strengths available : 50 mg and 100 mg

Form :injection

Dosage :Dosage In Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis :-The Simponi dose regimen is 50 mg administered by subcutaneous injection once a month.For patients with rheumatoid arthritis (RA), Simponi should be given in combination with methotrexate and for patients with psoriatic arthritis (PsA) or ankylosing spondylitis (AS), Simponi may be given with or without methotrexate or other nonbiologic Disease-Modifying Antirheumatic Drugs (DMARDs). For patients with RA, PsA, or AS, corticosteroids, non-biologic DMARDs, and/or NSAIDs may be continued during treatment with Simponi.

Dosage In Moderately To Severely Active Ulcerative Colitis :-The recommended Simponi induction dosage regimen is a 200-mg subcutaneous injection at Week 0, followed by 100 mg at Week 2, and then maintenance therapy with 100 mg every 4 weeks.

Storage :Store at 2 °C to 8 °C

Is the medicine FDA  approved : Yes

Date of Approval :24 April, 2009

Common side effects are cough, chills, body ache or pain, ear congestion, difficulty with breathing, headache, fever, muscle aches, loss of voice, sore throat, sneezing, unusual tiredness or weakness, stuffy or running nose.

Pack of 1 single dose